Tanespimycin
Tanespimycin (17-AAG) is an inhibitor of Hsp90 that selectively inhibits BT474 tumor cell Hsp90 (IC50: 5 nM).
| Catalog Number | T6290 |
| Alternative Name(s) | 17-AAG , CP 127374 , NSC 330507 , KOS 953 |
| Research Area | Cytoskeletal Signaling|||Metabolism|||Apoptosis|||Autophagy|||Microbiology/Virology |
| Molecular Formula | C31H43N3O8 |
| CAS# | 75747-14-7 |
| Purity | 99.34% |
| SMILES | CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(C)=C\C=C/[C@H](OC)[C@@H](OC(N)=O)\C(C)=C\[C@H](C)[C@H]1O)C2=O |
| Size | 10 mg |
| Supplier Page | https://www.targetmol.com/compound/Tanespimycin |
| Additional Information | https://www.targetmol.com/datasheet/T6290 |